Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions
about
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of diseasePathogenesis of rheumatoid arthritis: how early is early?Pivotal roles of GM-CSF in autoimmunity and inflammationDetection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritisImplication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis.Oncostatin M: development of a pleiotropic cytokine.Cytokines in asthma.Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation.Molecular control of steady-state dendritic cell maturation and immune homeostasis.Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cellsEffects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice.Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritisHematopoietic colony-stimulating factors: new players in tumor-nerve interactions.Sex hormone adjuvanting therapy in rheumatoid arthritis.Fc gamma receptor IIb on GM-CSF macrophages controls immune complex mediated inhibition of inflammatory signalsInterindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production bNatural killer cells trigger differentiation of monocytes into dendritic cells.Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment.Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis.Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.Positive influence of Methotrexate-Hydroxychloroquine combination on the expression of GM-CSF receptor on neutrophils of synovial fluid in rheumatoid arthritis.Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritisGranulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophilsNon-allergic eosinophilic inflammation.Human blood and synovial fluid neutrophils cultured in vitro undergo programmed cell death which is promoted by the addition of synovial fluidGranulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammationDeoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cellsPolyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis modelPulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis.Synovial fluid antigen-presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis.Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy.GM-CSF alters dendritic cells in autoimmune diseases.Targeting GM-CSF in inflammatory diseases.Selected cytokine pathways in rheumatoid arthritis.
P2860
Q24799657-E093CEFB-C7ED-40A6-9B94-F2F0E96F08E9Q24810459-F62E32FF-E84F-452B-81C9-C9058347FDCFQ26830824-A202E6CC-7C95-4C06-B79A-83F0613655A8Q33578241-ACBF59FD-7AD3-4313-9E68-2C6D96163098Q33579424-DF043381-C3DA-42BF-A663-1F4D694C9FD0Q33596027-6DF14FF5-63DF-4B2D-9189-6AE4C7D4DBE5Q33596672-1ED80CB9-CA74-421B-9691-6B295609350CQ33717312-B99DA6B6-CB16-4A63-8FD5-DA71A368A0D6Q33766708-8DAFF737-F46B-4C22-B5EB-49854505F4ACQ33882051-502BA7BF-712E-46D4-8E53-69DFD1AB0608Q33905638-2B3628DD-9E0C-450F-8073-A906EC12762CQ34059086-2AA96449-9E1D-4E85-8320-21AC473D5D57Q34184474-AB8052FB-148E-420C-A06E-81678303CF93Q34411088-2F772AAF-4A05-41EF-A210-83B7FD064825Q34663630-7AF6395C-6D3C-4068-BC62-F45D422A7D89Q34986972-C68B1EBA-3F02-4184-ACEC-2D5E12B9C427Q35361098-F79BBE2A-6B9D-410A-ADC3-EC4F57DB9AC7Q35549328-A94E5C45-1588-4D5A-B801-E1BC8CFFE1ABQ35605630-1622C025-C8AC-4627-A0F7-D7EDB7E57F40Q35816853-94EEAE4C-E0AF-4BEF-80EA-B439C0CC6483Q36007747-64006B4E-C199-41CE-8E6C-7E4B49F708D1Q36014211-951317C5-DBBA-46D1-B61E-ACC15EC6BDA5Q36109953-CF455934-0CED-4252-A881-6E7193E3247AQ36230031-15682B73-00F4-44DA-AC47-092FA5F8568BQ36265301-7E01906D-D4B1-467A-A352-25E5A544095FQ36356742-71F74A78-21C0-46C9-9E07-B23DD8D2C9A7Q36363029-CCE33480-69A8-4224-A3A2-7F82F5070278Q36419034-ADB2CE9F-87FE-4FFF-B3D8-CAFD8362781CQ36671708-3FCF479E-6339-4E73-B999-7FDBBD92F089Q37217530-77DF7ED0-8778-4A51-B0B4-3EC525DE51ABQ37369057-8ED34993-19AA-424D-94D7-743ED360D423Q37383845-6DDDB812-E2DB-4D80-A556-5C973D9369A7Q37427088-70722BBA-3F20-4FFE-92C7-ECF1EDF8CF72Q37468752-73A1A2FA-6083-495A-9802-ED6764A2CBF5Q37690033-51CADBD0-9ECD-42E9-BB23-41F8FBEFB282Q37897015-CA72EF12-BD49-4311-8C40-ED5EE7801C4BQ38055244-3C2B5832-440E-4111-ABD8-E24C3C14CC2AQ38115807-EAD68376-0DE2-48F7-B319-6A1BF78BA3ACQ38657999-48E0FEFC-6B8C-43E6-B76C-42293733070DQ38755912-424C8550-F353-45D6-86B5-4C47F1F4A77D
P2860
Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@ast
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@en
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@nl
type
label
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@ast
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@en
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@nl
prefLabel
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@ast
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@en
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@nl
P2093
P2860
P356
P1476
Cytokines in chronic inflammat ...... rheumatoid synovial effusions
@en
P2093
G S Firestein
K Kaushansky
N J Zvaifler
P2860
P304
P356
10.1172/JCI113971
P407
P577
1989-03-01T00:00:00Z